210 related articles for article (PubMed ID: 22449447)
1. Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice.
Vanleene M; Porter A; Guillot PV; Boyde A; Oyen M; Shefelbine S
Bone; 2012 Jun; 50(6):1317-23. PubMed ID: 22449447
[TBL] [Abstract][Full Text] [Related]
2. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).
Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P
Bone; 2001 Nov; 29(5):453-7. PubMed ID: 11704498
[TBL] [Abstract][Full Text] [Related]
3. The material basis for reduced mechanical properties in oim mice bones.
Camacho NP; Hou L; Toledano TR; Ilg WA; Brayton CF; Raggio CL; Root L; Boskey AL
J Bone Miner Res; 1999 Feb; 14(2):264-72. PubMed ID: 9933481
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the mineral in ductile and brittle cortical mouse bone.
Rodriguez-Florez N; Garcia-Tunon E; Mukadam Q; Saiz E; Oldknow KJ; Farquharson C; Millán JL; Boyde A; Shefelbine SJ
J Bone Miner Res; 2015 May; 30(5):786-95. PubMed ID: 25418329
[TBL] [Abstract][Full Text] [Related]
5. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
[TBL] [Abstract][Full Text] [Related]
6. Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone.
Miller E; Delos D; Baldini T; Wright TM; Pleshko Camacho N
Calcif Tissue Int; 2007 Sep; 81(3):206-14. PubMed ID: 17660935
[TBL] [Abstract][Full Text] [Related]
7. Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model.
Yao X; Carleton SM; Kettle AD; Melander J; Phillips CL; Wang Y
Ann Biomed Eng; 2013 Jun; 41(6):1139-49. PubMed ID: 23536112
[TBL] [Abstract][Full Text] [Related]
8. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
[TBL] [Abstract][Full Text] [Related]
9. Intrafibrillar mineralization deficiency and osteogenesis imperfecta mouse bone fragility.
Maghsoudi-Ganjeh M; Samuel J; Ahsan AS; Wang X; Zeng X
J Mech Behav Biomed Mater; 2021 May; 117():104377. PubMed ID: 33636677
[TBL] [Abstract][Full Text] [Related]
10. Multi-scale analysis of bone chemistry, morphology and mechanics in the oim model of osteogenesis imperfecta.
Bart ZR; Hammond MA; Wallace JM
Connect Tissue Res; 2014 Aug; 55 Suppl 1():4-8. PubMed ID: 25158170
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
[TBL] [Abstract][Full Text] [Related]
12. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.
Fratzl-Zelman N; Morello R; Lee B; Rauch F; Glorieux FH; Misof BM; Klaushofer K; Roschger P
Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918
[TBL] [Abstract][Full Text] [Related]
13. Tomographic imaging of collagen-mineral interaction: implications for osteogenesis imperfecta.
Landis WJ
Connect Tissue Res; 1995; 31(4):287-90. PubMed ID: 15612370
[TBL] [Abstract][Full Text] [Related]
14. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.
Fratzl-Zelman N; Schmidt I; Roschger P; Roschger A; Glorieux FH; Klaushofer K; Wagermaier W; Rauch F; Fratzl P
Bone; 2015 Apr; 73():233-41. PubMed ID: 25554599
[TBL] [Abstract][Full Text] [Related]
15. Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue.
Jepsen KJ; Schaffler MB; Kuhn JL; Goulet RW; Bonadio J; Goldstein SA
J Biomech; 1997; 30(11-12):1141-7. PubMed ID: 9456382
[TBL] [Abstract][Full Text] [Related]
16. Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment.
Bi X; Grafe I; Ding H; Flores R; Munivez E; Jiang MM; Dawson B; Lee B; Ambrose CG
J Bone Miner Res; 2017 Feb; 32(2):347-359. PubMed ID: 27649409
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse.
Misof BM; Roschger P; Baldini T; Raggio CL; Zraick V; Root L; Boskey AL; Klaushofer K; Fratzl P; Camacho NP
Bone; 2005 Jan; 36(1):150-8. PubMed ID: 15664013
[TBL] [Abstract][Full Text] [Related]
18. The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta.
Delos D; Yang X; Ricciardi BF; Myers ER; Bostrom MP; Camacho NP
J Orthop Res; 2008 Feb; 26(2):153-64. PubMed ID: 17729310
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
[TBL] [Abstract][Full Text] [Related]
20. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
Camacho NP; Carroll P; Raggio CL
Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
